Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jorge J Castillo

Showing results (41-50 of 342) with videos related to

Pageof 35
Sort By:
Expert Review of Anticancer Therapy|April 3, 2025
Current and emerging treatment perspectives for adults with Waldenström macroglobulinemiaAlberto Guijosa, Shayna Sarosiek, Jorge J Castillo
Hematology/Oncology Clinics of North America|September 8, 2018
Monoclonal Antibodies for Waldenström MacroglobulinemiaAndres Dominguez, Efstathios Kastritis, Jorge J Castillo
The Oncologist|February 1, 2023
Managing Ibrutinib-Intolerant Patients With B-Cell MalignanciesJavier Muñoz, Shayna Sarosiek, Jorge J Castillo
Mediterranean Journal of Hematology and Infectious Diseases|March 14, 2025
Waldenström Macroglobulinemia - A State-of-the-Art Review: Part 2- Focus on TherapyMichele Bibas, Shayna Sarosiek, Jorge J Castillo
Hematology/Oncology Clinics of North America|May 21, 2023
Waldenström Macroglobulinemia: A Myriad of Effective Treatment Options, but Still Work to be DoneJorge J Castillo, Shayna Sarosiek, Prashant Kapoor
Pathology Research International|December 15, 2010
Immunophenotypical Switch versus Tumor Heterogeneity in a Patient with HIV-Associated Diffuse Large B-Cell LymphomaJorge J Castillo, Tina Rizack, Diana Treaba
Mediterranean Journal of Hematology and Infectious Diseases|July 10, 2024
Waldenström Macroglobulinemia - A State-of-the-Art Review: Part 1: Epidemiology, Pathogenesis, Clinicopathologic Characteristics, Differential Diagnosis, Risk Stratification, and Clinical ProblemsMichele Bibas, Shayna Sarosiek, Jorge J Castillo
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 14, 2015
Treatment selection and outcomes in early-stage classical Hodgkin lymphoma: analysis of the National Cancer Data BaseAdam J Olszewski, Rajesh Shrestha, Jorge J Castillo
Leukemia Research|August 13, 2013
Multiple myeloma-induced hyperammonemic encephalopathy: an entity associated with high in-patient mortalityAnthony Pham, John L Reagan, Jorge J Castillo
Expert Opinion on Investigational Drugs|November 25, 2011
CAL-101: a phosphatidylinositol-3-kinase p110-delta inhibitor for the treatment of lymphoid malignanciesJorge J Castillo, Michael Furman, Eric S Winer
Pageof 35

Showing results (41-50 of 342) with videos related to

Sort By:
Pageof 35
Expert Review of Anticancer Therapy|April 3, 2025
Current and emerging treatment perspectives for adults with Waldenström macroglobulinemiaAlberto Guijosa, Shayna Sarosiek, Jorge J Castillo
Hematology/Oncology Clinics of North America|September 8, 2018
Monoclonal Antibodies for Waldenström MacroglobulinemiaAndres Dominguez, Efstathios Kastritis, Jorge J Castillo
The Oncologist|February 1, 2023
Managing Ibrutinib-Intolerant Patients With B-Cell MalignanciesJavier Muñoz, Shayna Sarosiek, Jorge J Castillo
Mediterranean Journal of Hematology and Infectious Diseases|March 14, 2025
Waldenström Macroglobulinemia - A State-of-the-Art Review: Part 2- Focus on TherapyMichele Bibas, Shayna Sarosiek, Jorge J Castillo
Hematology/Oncology Clinics of North America|May 21, 2023
Waldenström Macroglobulinemia: A Myriad of Effective Treatment Options, but Still Work to be DoneJorge J Castillo, Shayna Sarosiek, Prashant Kapoor
Pathology Research International|December 15, 2010
Immunophenotypical Switch versus Tumor Heterogeneity in a Patient with HIV-Associated Diffuse Large B-Cell LymphomaJorge J Castillo, Tina Rizack, Diana Treaba
Mediterranean Journal of Hematology and Infectious Diseases|July 10, 2024
Waldenström Macroglobulinemia - A State-of-the-Art Review: Part 1: Epidemiology, Pathogenesis, Clinicopathologic Characteristics, Differential Diagnosis, Risk Stratification, and Clinical ProblemsMichele Bibas, Shayna Sarosiek, Jorge J Castillo
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 14, 2015
Treatment selection and outcomes in early-stage classical Hodgkin lymphoma: analysis of the National Cancer Data BaseAdam J Olszewski, Rajesh Shrestha, Jorge J Castillo
Leukemia Research|August 13, 2013
Multiple myeloma-induced hyperammonemic encephalopathy: an entity associated with high in-patient mortalityAnthony Pham, John L Reagan, Jorge J Castillo
Expert Opinion on Investigational Drugs|November 25, 2011
CAL-101: a phosphatidylinositol-3-kinase p110-delta inhibitor for the treatment of lymphoid malignanciesJorge J Castillo, Michael Furman, Eric S Winer
Pageof 35